Terns Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TERN and other ETFs, options, and stocks.About TERN
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program.
CEOAmy L. Burroughs
CEOAmy L. Burroughs
Employees59
Employees59
HeadquartersFoster City, California
HeadquartersFoster City, California
Founded2017
Founded2017
Employees59
Employees59
TERN Key Statistics
Market cap2.03B
Market cap2.03B
Price-Earnings ratio-21.86
Price-Earnings ratio-21.86
Dividend yield—
Dividend yield—
Average volume7.42M
Average volume7.42M
High today$23.31
High today$23.31
Low today$20.30
Low today$20.30
Open price$20.52
Open price$20.52
Volume3.93M
Volume3.93M
52 Week high$23.31
52 Week high$23.31
52 Week low$1.87
52 Week low$1.87
Stock Snapshot
As of today, Terns Pharmaceuticals(TERN) shares are valued at $22.67. The company's market cap stands at 2.03B, with a P/E ratio of -21.86.
During the trading session on 2025-11-14, Terns Pharmaceuticals(TERN) shares reached a daily high of $23.31 and a low of $20.30. At a current price of $22.67, the stock is +11.7% higher than the low and still -2.7% under the high.
Trading activity shows a volume of 3.93M, compared to an average daily volume of 7.42M.
Over the past 52 weeks, Terns Pharmaceuticals(TERN) stock has traded between a high of $23.31 and a low of $1.87.
Over the past 52 weeks, Terns Pharmaceuticals(TERN) stock has traded between a high of $23.31 and a low of $1.87.
Analyst ratings
100%
of 11 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own TERN. This list is generated using Robinhood data, and it’s not a recommendation.